Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Long-Term Debt Issuances (2009 - 2025)

Updated

Vistagen Therapeutics (VTGN) posted Long-Term Debt Issuances of $1.02 million for FY2026 (year ended Mar 31, 2026).

Analysis

Vistagen Therapeutics (VTGN) Long-Term Debt Issuances (2009 - 2025) Analysis & Trends

Since FY2009, Vistagen Therapeutics has reported Long-Term Debt Issuances for 7 fiscal years.

  • Annual Long-Term Debt Issuances shows a five-year compound annual growth rate of 35.4% (FY2021 to FY2026).
  • The FY2026 figure stands as the highest annual Long-Term Debt Issuances since FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 805,000.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 9.98 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.02 Mn
Jun 30, 2020 224,400.00
Dec 31, 2013 64,000.00
Sep 30, 2013 -6.89 Mn
Jun 30, 2013 6.92 Mn
Dec 31, 2012 2.19 Mn
Jun 30, 2012 3.70 Mn
Mar 31, 2012 3.70 Mn
Sep 30, 2011 -3.70 Mn
Jun 30, 2011 3.70 Mn
Mar 31, 2011 30.00
Mar 31, 2010 30.00
Mar 31, 2009 500.00
API Access

Vistagen Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=VTGN&period=max&api_key=YOUR_API_KEY